If you made any changes in Pure these will be visible here soon.

Publications 2016 2019

2019

New tricks of prolyl oligopeptidase inhibitors - A common drug therapy for several neurodegenerative diseases

Svarcbahs, R., Julku, U., Kilpelainen, T., Kyyrö, M., Jäntti, M. & Myohänen, T. T., Mar 2019, In : Biochemical Pharmacology. 161, p. 113-120 8 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

2018

Combination of CDNF and Deep Brain Stimulation Decreases Neurological Deficits in Late-stage Model Parkinson's Disease

Huotarinen, A., Penttinen, A-M., Bäck, S., Voutilainen, M. H., Julku, U., Piepponen, T. P., Männistö, P. T., Saarma, M., Tuominen, R., Laakso, A. & Airavaara, M., 15 Mar 2018, In : Neuroscience. 374, p. 250-263 14 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse

Julku, U. H., Panhelainen, A. E., Tiilikainen, S. E., Svarcbahs, R., Tammimäki, A. E., Piepponen, T. P., Savolainen, M. H. & Myöhänen, T. T., Jan 2018, In : Molecular Neurobiology. 55, 1, p. 470-482 13 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo

Svarcbahs, R., Julku, U. H., Norrbacka, S. & Myöhänen, T. T., 2018, In : Scientific Reports. 8, 1, 18 p., 1552.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File
2017

Prolyylioligopeptidaasin estäjällä Parkinsonin tautia vastaan?

Svarcbahs, R., Julku, U. & Myöhänen, T. T., Jan 2017, In : Duodecim. 133, 1, p. 89 1 p.

Research output: Contribution to journalArticleProfessional